Navigation Links
Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services
Date:5/22/2013

WALLINGFORD, Conn., May 22, 2013 /PRNewswire/ -- Z-Medica, a leading developer and marketer of hemostatic agents, announced today it has launched the first-ever line of products designed to meet the unique needs of Emergency Medical Services. The line includes QuikClot® EMS 4x4 Dressing, QuikClot® EMS TraumaPad®, and QuikClot® EMS Rolled Gauze™, all custom-designed to help responders stop bleeding fast and keep patients alive until they can be transported to a hospital or trauma center. The line includes products designed and packaged for faster deployment and more efficient inventory management for EMS centers.

Each product can be used to control bleeding associated with a wide range of needs found in EMS settings including car accidents, assaults, workplace or at-home injuries, falls and other events leading to cuts or lacerations. Now in their third generation, QuikClot products in the new EMS line are infused with kaolin, a mineral that has been clinically shown to initiate the body's natural coagulation cascade, rapidly accelerating the clotting process without causing any exothermic reaction.

"Blood loss from traumatic injury causes approximately 50,000 deaths a year in the United States alone," said Doug Kay , Director of Marketing for Z-Medica. "We are launching this new line of products to help ensure the first people to arrive on the scene of an accident have the resources they need to stop bleeding fast and save lives."

To help EMS teams manage inventory better, the line of QuikClot® EMS products will be distributed with fewer units in smaller packages compared to those typically found in a hospital or military setting. For example, QuikClot® EMS 4x4 Dressing will be offered in packs of three rather than five, and QuikClot® EMS Rolled Gauze™ will be 4-foot instead of standard 12-foot rolls. The smaller packaging also provides better value at a time when many EMS teams are facing significant budget pressure. 

"EMS providers across the country are facing budget issues and an increase in the number of calls," said Robert Huebner , Director of Pre-Hospital Programs for Z-Medica. "Our new line of QuikClot® EMS Products can alleviate some of these issues, with products specifically sized and priced to meet the most common hemostasis needs in EMS settings."

The EMS Family of Products will be sold through a world-class team of authorized Z-Medica resellers. In addition, Z-Medica will launch an online training program for EMS personnel that will be available this summer.

About Z-Medica® LLC

Z-Medica LLC is a medical device company founded in 2002 developing fast acting, easy to use, hemostasis products that stop bleeding wherever it occurs, making it possible to save lives and improve patient outcomes.  The company manufactures and markets a portfolio of QuikClot® hemostasis products for use by healthcare professionals, first responders, law enforcement officers, consumers and the military.

Based on tests conducted by the Naval Medical Research Center and the U.S. Army Institute for Surgical Research, the Committee on Tactical Combat Casualty Care (CoTCCC) recommended QuikClot Combat Gauze® as the hemostatic agent for the Department of Defense and for use by all U.S. Military Forces as the first line treatment of traumatic bleeding. QuikClot® products are developed and manufactured in the United States. Z-Medica LLC is a privately-held company based in Wallingford, CT. For more information, visit www.z-medica.com/EMS/Home.aspx  


'/>"/>
SOURCE Z-Medica LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Combat Medical Systems buyout of Z-Medica ushers in new growth
2. Z-Medica Announces Expanded CE Indications for QuikClot Hemostatic Dressings Supporting Broader Use in Surgical Wound Care
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
5. Mylan Launches Generic Version of Zyprexa® Tablets
6. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
7. American Academy of Family Physicians Foundation Launches Cities for Life
8. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
9. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
10. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
11. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... DUBLIN , May 26, 2017  Endo International plc ... Campanelli , President and CEO, will represent the Company in ... Global Healthcare Conference on Tuesday, June 13, 2017 at 10:40 ... held at Terranea Resort in Rancho Palos Verdes, ... archive for the event will be available on the Company,s ...
(Date:5/24/2017)... HAMPTON, Va. , May 24, 2017 /PRNewswire/ ... ivWatch Original Equipment Manufacturer (OEM) Board to enable ... technology with patient monitoring systems, infusion pumps and ... products, OEMs will be able to help health ... care and reduced risks related to IV therapy. ...
(Date:5/22/2017)... 22, 2017  Lilac Corp, the company that ... launch of a new website . The ... a clinical study that showed surprising clearance of ... in individuals suffering from HPV warts, precancerous, or ... are no other treatments that clear the virus. ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s Aresty ... executives as a kick-off to the fifth annual CEO Connection Mid-Market Convention. ... University of Pennsylvania campus, followed by the two-day convention, which will target C-suite ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the ... two year study conducted by the University of Saskatchewan in partnership with PotashCorp, ... potash brine-impacted groundwater. As a part of the study, batch adsorption experiments were ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... consultations to communities in northern Virginia and DC, is announcing a cooperative charity ... patients with Alzheimer’s and other disorders that lead to memory impairment. , The ...
(Date:6/27/2017)... IL (PRWEB) , ... June 27, 2017 , ... ... considering a cosmetic treatment, according to survey data released today by the ... on Cosmetic Dermatologic Procedures indicates the percentage of consumers considering a cosmetic ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
Breaking Medicine News(10 mins):